Key facts
- It has raised $6.0M; the latest was Seed Round ($6.0M) in Oct 2025.
- Notable investors include 645 Ventures, 97212 Ventures, State Of Mind Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Inner Balance
- ·The full record, as it builds
Funding rounds
No funding rounds for Inner Balance are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inner Balance
Provider of prescription hormone enrichment treatment services intended to support whole-body hormonal balance and skin health using bioidentical ingredients. The company offers physician-developed, plant-based formulations and personalized prescription care, enabling women seeking hormonal and skin support to improve well-being through treatments matched to their body's natural hormone needs.
- Sector
- Healthcare
- HQ
- Boise, ID, United States
- Founded
- 2023
- Employees
- 6
- Website
- innerbalance.com/
- Ownership
- Privately Held (backing)
Inner Balance doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inner Balance shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inner Balance in its N-PORT filings yet. We sweep new filings monthly.